AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Which Is Better For Tax Lots Etf Or Mutual Fund Retirement
Tax lots affect cost basis and gains in retirement accounts. This piece compares ETFs and mutual funds to help you choose.
25,093 articles
Stock Market Today, Feb.: CoreWeave Financing Fallout Shakes AI Bets
Stocks wiggle as CoreWeave drops on news of Blue Owl’s failed $4B debt placement. Experts say the financing hiccup co...
Pixelworks (PXLW) 2025 Earnings Outlook and Analysis
Pixelworks' 2025 earnings cycle highlights a niche semiconductor with rising AI-driven display capabilities. This art...
Missed Nvidia? Missed Tesla? AI Marketing Stock at $0.91
RAD Intel debuts a Regulation A+ offering at $0.91 per share, pitching an AI-driven marketing engine as the next oppo...
Google Just Give Investors 30B Reasons for SpaceX IPO
A hypothetical SpaceX IPO could ride a powerful tailwind if a Google cloud deal brings $30 billion in AI compute reve...
Gamestop Next Berkshire Hathaway? Could It Happen
Investors often wonder if a smaller company can replicate Berkshire Hathaway’s long-term success. This analysis looks...
Bruno Mars Shares Official Tracklist and Financial Comeback
Bruno Mars is back with a new solo project, and the tracklist drop isn’t just music news—it’s a case study in modern ...
Adobe Stock Dropped After Earnings: What Investors Miss
Adobe stock dropped after earnings despite solid results, leaving many investors puzzled. This article unpacks the fo...
Amplitech (AMPG) 2026 Earnings Outlook and Strategy
Investors are watching amplitech (ampg) for clues about growth, margins, and 2026 strategy. This article breaks down ...
I Feel Like It’s 1999 Again: Oracle Stock Warns Investors
Oracle confronts a fresh wave of investor anxiety as a heavy OpenAI backlog, negative cash flow, and mounting leverag...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
NASA Delays Moon Mission as Rocket Rollback Moves Ahead Today
NASA slows plans for Artemis II after engineers find a helium-flow issue in the upper stage, forcing a rollback to th...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status